OpenURL Connection Search

Select item for more details and to access through your institution.

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
Published in:
2012
By:
- Parving, Hans-Henrik;
- Brenner, Barry M;
- McMurray, John Jv;
- de Zeeuw, Dick;
- Haffner, Steven M;
- Solomon, Scott D;
- Chaturvedi, Nish;
- Persson, Frederik;
- Nicolaides, Maria;
- Richard, Alexia;
- Xiang, Zhihua;
- Armbrecht, Juergen;
- Pfeffer, Marc A;
- (on behalf of the ALTITUDE investigators)
Publication type:
Journal Article
Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE).
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2012, v. 13, n. 3, p. 387, doi. 10.1177/1470320311434818
By:
- Parving, Hans-Henrik;
- Brenner, Barry M;
- McMurray, John JV;
- de Zeeuw, Dick;
- Haffner, Steven M;
- Solomon, Scott D;
- Chaturvedi, Nish;
- Persson, Frederik;
- Nicolaides, Maria;
- Richard, Alexia;
- Xiang, Zhihua;
- Armbrecht, Juergen;
- Pfeffer, Marc A
Publication type:
Article
A putative placebo comparison of the SCOPE and LIFE trials.
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2004, v. 5, n. 2, p. 59, doi. 10.3317/jraas.2004.011
By:
- Meredith, Peter A;
- Murray, Lilian S;
- McMurray, John JV
Publication type:
Article
Introduction.
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2004, v. 5, n. 1S, p. S1, doi. 10.1177/14703203040050010101
By:
- McMurray, John JV
Publication type:
Article
Angiotensin inhibition in heart failure.
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2004, v. 5, n. 1S, p. S17, doi. 10.3317/jraas.2004.019
By:
- McMurray, John JV
Publication type:
Article
Angiotensin receptor blockers in heart failure.
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2003, v. 4, n. 3, p. 171, doi. 10.3317/jraas.2003.027
By:
- Östergren, Jan;
- McMurray, John JV
Publication type:
Article
Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT?
Published in:
Journal of the Renin-Angiotensin-Aldosterone System, 2001, v. 2, n. 2, p. 89, doi. 10.3317/jraas.2001.017
By:
- McMurray, John JV
Publication type:
Article
Reply to 'Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials'.
Published in:
European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1994, doi. 10.1002/ejhf.2686
By:
- McDowell, Kirsty;
- Jhund, Pardeep S;
- McMurray, John JV
Publication type:
Article
Vericiguat, sacubitril/valsartan and more evidence that we are failing our patients.
Published in:
2022
By:
- Butt, Jawad H.;
- McMurray, John J.V.;
- McMurray, John Jv
Publication type:
Editorial
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
Published in:
2019
By:
- McMurray, John J.V.;
- DeMets, David L.;
- Inzucchi, Silvio E.;
- Køber, Lars;
- Kosiborod, Mikhail N.;
- Langkilde, Anna M.;
- Martinez, Felipe A.;
- Bengtsson, Olof;
- Ponikowski, Piotr;
- Sabatine, Marc S.;
- Sjöstrand, Mikaela;
- Solomon, Scott D.;
- McMurray, John JV;
- DeMets, David L;
- Inzucchi, Silvio E;
- Kosiborod, Mikhail N;
- Langkilde, Anna Maria;
- Martinez, Felipe A;
- Sabatine, Marc S;
- Solomon, Scott D
Publication type:
journal article
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Published in:
2015
By:
- Kao, David P.;
- Lewsey, James D.;
- Anand, Inder S.;
- Massie, Barry M.;
- Zile, Michael R.;
- Carson, Peter E.;
- McKelvie, Robert S.;
- Komajda, Michel;
- McMurray, John JV;
- Lindenfeld, JoAnn
Publication type:
journal article
A randomised trial of a pre-synaptic stimulator of DA<sub>2</sub>-dopaminergic and α<sub>2</sub>-adrenergic receptors on morbidity and mortality in patients with heart failure
Published in:
European Journal of Heart Failure, 2008, v. 10, n. 1, p. 89, doi. 10.1016/j.ejheart.2007.10.012
By:
- Torp-Pedersen, Christian;
- Køber, Lars;
- Carlsen, Jan E.;
- Akkan, Dilek;
- Bruun, Niels E.;
- Dacoronias, Dimitri;
- Dickstein, Kenneth;
- Haghfelt, Torben;
- Öhlin, Hans;
- McMurray, John JV
Publication type:
Article
Effects of apixaban compared with warfarin as gain in event-free time – a novel assessment of the results of the ARISTOTLE trial.
Published in:
European Journal of Preventive Cardiology, 2020, v. 27, n. 12, p. 1311, doi. 10.1177/2047487319886959
By:
- Berglund, Erik;
- Wallentin, Lars;
- Oldgren, Jonas;
- Renlund, Henrik;
- Alexander, John H;
- Granger, Christopher B;
- Hohnloser, Stefan H;
- Hylek, Elaine M;
- Lopes, Renato D;
- McMurray, John JV;
- Lytsy, Per
Publication type:
Article
Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study.
Published in:
Clinical Epidemiology, 2018, v. 10, p. 917, doi. 10.2147/CLEP.S164795
By:
- Rørth, Rasmus;
- Fosbøl, Emil L;
- Kragholm, Kristian;
- Mogensen, Ulrik M;
- Jhund, Pardeep S;
- Petrie, Mark C;
- Torp-Pedersen, Christian;
- Gislason, Gunnar H;
- McMurray, John JV;
- Køber, Lars;
- Kristensen, Søren L
Publication type:
Article

Found: 14